Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07668934 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

TAF in Early/Middle Pregnancy With CHB

Study acronym: TAF;CHB
StatusEnrolling by Invitation
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
The goal of this clinical trial is to study the efficacy and safety of Tenofovir alafenamide (TAF) vs Tenofovir disoproxil fumarate(TDF) in early and middle pregnancy with chronic hepatitis B.
Trial Details
NCT Number NCT07668934
Lead Sponsor The Third Affiliated Hospital of Guangzhou Medical University
Collaborators: Second Affiliated Hospital of Guangzhou Medical University, Qingyuan People's Hospital
Conditions
(from sponsor)		 Hepatitis B Infection, Pregnant Women, Early Pregnancy
Related terms Hepatitis B
Enrollment 816 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov